FDA inspectors found the company’s verification study for the conformal coating for pre-amp photometer boards was conducted after its validation study was completed, and the company was unable to provide documentation of the production of the re-designed photometer boards used in validation studies.
Records also failed to establish the company’s conformal coating application method and the minimal thickness required on the board.
Related Articles on FDA Warning Letters:
Zoll Gets FDA Warning Letter on Defibrillator Battery Life
FDA Warns Companies to Stop Making MRSA Claims for OTC Products
Johnson & Johnson Loses Case on Allegedly Fraudulent Marketing Practices, Ordered to Pay $257M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.